Document Detail


Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome.
MedLine Citation:
PMID:  9700118     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Intratracheal administration of surfactant and inhaled nitric oxide (INO) have had variable effects in clinical trials on patients with acute respiratory distress syndrome (ARDS). We hypothesized that combined treatment with exogenous surfactant and INO may have effects in experimental ARDS. After intravenous infusion of oleic acid in adult rabbits and 4-6 h of ventilation, there was more than a 40% reduction in both dynamic compliance (Cdyn) of the respiratory system and functional residual capacity (FRC), a 50% increment of respiratory resistance (Rrs), a 70% reduction in PaO2 /FIO2, and an increase in intrapulmonary shunting (Q S/Q T) from 4.4 to 33.5%. The animals were then allocated to groups receiving (1) neither surfactant nor INO (control), (2) 100 mg/kg of surfactant (S) administered intratracheally, (3) 20 ppm INO (NO), or (4) 100 mg/kg of surfactant and 20 ppm INO (SNO), and subsequently ventilated for 6 h. After the period of ventilation, the animal lungs were used for analysis of disaturated phosphatidylcholine (DSPC) and total proteins (TP) in bronchoalveolar lavage fluid (BALF), and for determination of alveolar volume density (VV). The animals in the control group had the lowest survival rate, and no improvement in lung mechanics and blood oxygenation, whereas those in the S group had a modest but statistically significant improvement in Cdyn, Rrs, PaO2 and FRC, reduced Q S/Q T, lowered minimum surface tension (gammamin) of BALF, and increased DSPC/ TP and alveolar VV. The NO group had increased PaO2 and reduced Q S/Q T. The SNO group showed improved Cdyn, Rrs, FRC, DSPC/TP, alveolar VV, and gammamin of BALF comparable to the S group, but there was a further increase in survival rate and PaO2, and additional reduction in Q S/Q T and TP in BALF. These results indicate that, in this animal model of ARDS, a combination of surfactant therapy and INO is more effective than either treatment alone.
Authors:
G F Zhu; B Sun; S F Niu; Y Y Cai; K Lin; R Lindwall; B Robertson
Related Documents :
24952038 - Comparison of muscle paralysis after intravenous and intraosseous administration of suc...
1622168 - Effects of cefetamet (ro 15-8074) on treponema pallidum and experimental syphilis.
10997948 - Disposition and toxicity of a mixed backbone antisense oligonucleotide, targeted agains...
3556838 - Teratologic evaluation of 2-phenoxyethanol in new zealand white rabbits following derma...
20443508 - Intensity modulated radiotherapy of non-small-cell lung cancer incorporating spect vent...
7452678 - Antiarrhythmic activity of amitriptyline analogues in conscious dogs after myocardial i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of respiratory and critical care medicine     Volume:  158     ISSN:  1073-449X     ISO Abbreviation:  Am. J. Respir. Crit. Care Med.     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-09-03     Completed Date:  1998-09-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421642     Medline TA:  Am J Respir Crit Care Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  437-43     Citation Subset:  AIM; IM    
Affiliation:
Children's Hospital Research Institute; Department of Pulmonology, Zhongshan Hospital, Shanghai Medical University, Shanghai 200032, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Animals
Disease Models, Animal
Drug Synergism
Drug Therapy, Combination
Nitric Oxide / administration & dosage*,  therapeutic use
Oleic Acid
Organ Size
Pulmonary Surfactants / administration & dosage*,  therapeutic use
Rabbits
Respiratory Distress Syndrome, Adult / chemically induced,  drug therapy*,  physiopathology
Respiratory Function Tests
Chemical
Reg. No./Substance:
0/Pulmonary Surfactants; 10102-43-9/Nitric Oxide; 112-80-1/Oleic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis.
Next Document:  Increased intestinal permeability is associated with the development of multiple organ dysfunction s...